Previous Close | 26.35 |
Open | 30.35 |
Bid | 30.80 |
Ask | 33.25 |
Strike | 450.00 |
Expire Date | 2025-01-17 |
Day's Range | 30.35 - 32.40 |
Contract Range | N/A |
Volume | |
Open Interest | 204 |
The company entered into a buyout agreement with Eli Lilly.
(Bloomberg) -- A well-timed options trade in Point Biopharma Global Inc. stands to hand some investors upwards of $500,000 after Eli Lilly & Co.’s agreement to acquire the company sent its stock surging.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsWhy a US Recession Is Still Likely — and Coming SoonAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Stocks, Bonds Sell Off as Volatility Makes Return: Markets WrapJPMorgan’s Dimon Predicts 3.5-Day
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.